Prostatype Genomics AB (OSTO:PROGEN) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Days Payable?

Prostatype Genomics AB's average Accounts Payable for the three months ended in Jun. 2024 was kr9.45 Mil. Prostatype Genomics AB's Cost of Goods Sold for the three months ended in Jun. 2024 was kr0.00 Mil.

The historical rank and industry rank for Prostatype Genomics AB's Days Payable or its related term are showing as below:

OSTO:PROGEN's Days Payable is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 61.87
* Ranked among companies with meaningful Days Payable only.

Prostatype Genomics AB's Days Payable stayed the same from Dec. 2022 (0.00) to Jun. 2024 (0.00). stayed the same

Prostatype Genomics AB Days Payable Historical Data

The historical data trend for Prostatype Genomics AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Days Payable Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Days Payable

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Prostatype Genomics AB's Days Payable

For the Diagnostics & Research subindustry, Prostatype Genomics AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prostatype Genomics AB's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prostatype Genomics AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Prostatype Genomics AB's Days Payable falls into.

Prostatype Genomics AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Prostatype Genomics AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2.184	+	9.448)	/	2 )	/	-2.372	*	365
=	5.816					/	-2.372	*	365
=	N/A

Prostatype Genomics AB's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (9.448	+	0)	/	1 )	/	0	*	365 / 4
=	9.448					/	0	*	365 / 4
=	N/A

Prostatype Genomics AB Days Payable Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB Headlines

No Headlines